Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-procedure Antibiotic Prophylaxis for Cardiac Electrical Device Implantation (ABxFREE)
NCT04146883Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Aug 2019
- Primary completion
- Aug 2020
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Randomised, open-label trial of cefalexin and cefazolin in post-operative infection (2 arms), sponsored by National Cheng Kung University Hospital. Primary endpoint: Cardiac implantable electronic device related infection at 1 year. Status: unknown.
02
Drugs
cefalexincefazolin
03
Conditions
post-operative infection
Beyond the preview
Go deeper on NCT04146883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04146883.